Page 5 - Study Population News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study Design and Subjects This study has used data from the prevalence study of selected chronic non-communicable diseases in Nepal. This is a population-based, nationwide cross-sectional survey conducted from 2016 to 2018 in all seven provinces of Nepal. Data were collected through a multistage cluster sampling with a mix of probability proportionate to size (PPS) and systematic random sampling. The detailed methodology has been presented elsewhere. 18 Males and females aged ⩾20 years and residents in the study area for at least the last 6 months were eligible for participation in the stud...

Preliminary analysis (n=176) demonstrates favorable safety and tolerability; data provide a strong signal of clinical benefit for subjects reporting one or more comorbidities Topline data from full study population of 350 patients and results of second study of KB109 are expected in the first quarter of 2021 LEXINGTON, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced positive interim results from the K031 non-IND controlled clinical study evaluating outpatients with mild to moderate COVID-19 disease. Patients in this non-IND clinical study wer...

Like in 40-year-olds. i don't want to know now. not that i'm 40. just to be clear. i wouldn't want to know at this stage of my life. it would be in the back of my head and depress me. a psychotherapist said to me, she would be worried that people would commit suicide. >> let's look at the glass half full. this could actually lead to some sort of effective treatment. >> that is the exciting thing about it. right now, if you want to test out a drug to see if it prevents alzheimer's, it is hard to do. you give it to 100 people. most of them aren't going to get alzheimer's. if you had 100 people t...